SPCG-19 Investigator Meeting in Sandefjord Strengthens Collaboration Across the Nordic Countries

The SPCG-19 Investigator Meeting was recently held at Scandic Park Sandefjord in Norway, bringing together investigators, study nurses, and collaborators from across the Nordic countries.

The meeting focused on study progress, collaboration, and strategies to ensure continued high-quality data collection and follow-up in the SPCG-19 trial. Representatives from each participating country presented updates on recruitment and study status, followed by focused discussion groups for investigators and study nurses.

The group explored ideas and designs for future SPCG studies. Several new research topics and study concepts were discussed, with a shared ambition to strengthen Nordic collaboration in prostate cancer research.

Participants left Sandefjord with renewed energy and shared commitment to the study’s goals. The SPCG-19-team would like to thank all attendees for their contributions and active participation throughout the meeting.

SPCG-19 investigators and study nurses in Sandefjord, September 2025.